Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

gn up for email alerts and get RSS feeds, please visit www.CellTherapeutics.com.

Forward-Looking Statements
This press release contains "forward-looking" statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development and our ability to submit the above-referenced tosedostat data to the FDA in the coming weeks. Such statements are subject to risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the Company's securities. Specifically, the risks and uncertainties that could affect our ability to address FDA requests or the development of tosedostat more generally include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with tosedostat in particular including, without limitation, the potential failure of tosedostat to prove safe and effective as determined by the FDA and/or the European Medicines Agency; determinations by regulatory, patent, and administrative governmental authorities; competitive factors; technological developments; costs of developing and producing tosedostat; the risk that the FDA may expand its information request or initiate a complete clinical hold or take other actions; and the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission, including, without limitation, the Company's most recent filings on Forms 10-K, 10-Q and 8-K. The Company can give no assurances that any results or events projected or contemplated by its forward-looking statements will in fact occur and the Company cautions you not to place undue reliance on these statements. The Company undertakes no duty to update these forward-looking statements to reflect any future events, d
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Un fournisseur mondial de ... l,hypertension, le diabète et les troubles thyroïdiens en ... plateformes éducatives gratuites et d,une conférence majeure dédiée ... http://photos.prnewswire.com/prnh/20150630/227090 ) , Les formations ... , Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... , July 3, 2015 ... bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung ... zu haben. Mit dieser Übernahme dringt Lupin ... einem Umsatz von 765 Mrd. RUB im ... der Welt gehörte (IMS Health). Seit über ...
(Date:7/2/2015)... , July 2, 2015 Leading organizations ... capture critical product and market insights in internal ... to employee-based studies, it is essential for executives ... internal employees to capture critical business-related insights. ... firm, Best Practices, LLC, most benchmarked companies find ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... , ARDEE, Ireland, Nov. 19 Warner ... of its previously announced secondary offering of 20,000,000 of its ... per share. The selling shareholders include funds affiliated with ... by CCMP Capital) and Thomas H. Lee Partners, L.P., certain ...
... , , LYON, France, Nov. 19 ... dangerous and illegal medicines, Operation Pangea II, involving 24 ... Organization,s International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight ... long global initiative resulted in a series of arrests ...
Cached Medicine Technology:Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new High ... of media attention. In an effort to spread the news, a comprehensive review ... days many people are feeling overwhelmed by stress and fatigue," reports Hendricks. "Many ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Renowned ... the dates for the 2016 Dallas Rhinoplasty Symposium . To be held from ... the meeting will be held at the Westin Galleria Dallas. , Designed to take ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the rage ... blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce a new ... boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a variety ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... Sept. 17 LifeNet Health, a leading,biomedical and ... & Wound Allograft Institute" in affiliation with The ... largest and most progressive,organ and tissue recovery organizations ... Wound Institute" will directly serve the needs of ...
... say , , MONDAY, Sept. 17 (HealthDay News) -- U.S. ... crucial role in the ability of breast cancer cells ... factor AP2C (TFAP2C) controls multiple pathways of estrogen signaling ... and may help explain differences in the effectiveness of ...
... This release is available in Spanish . , ... feelings and needs. If the parents or caregivers cannot find ... might react sharply and shake the baby. The violent shake ... result, the infant stops crying. For this reason, this behaviour ...
... American College of Physicians (ACP) will publish "The Fenway ... Dr. Ken Mayer, and Hilary Goldhammer of The Fenway ... of Beth Israel Deaconess Medical Center, the textbook is ... the unique health care needs of sexual and gender ...
... becomes available, researchers must recruit hundreds or thousands of ... these patients is often difficult. Many potential candidates are ... do logistical hurdles. As a result, patients miss out ... new therapies take longer to reach the public., In ...
... Sept. 17 Fauquier Health,System of Warrenton, Virginia ... Food service professionals are all too familiar with,traveling ... product,samples in the hopes of winning a sale. ... to apply the health sytem,s long-standing,commitment to individualized ...
Cached Medicine News:Health News:LifeNet Health Establishes 'The Skin & Wound Allograft Institute' 2Health News:Shaking may cause brain damage and serious long-term effects to infants 2Health News:American College of Physicians publishes 'The Fenway Guide to LGBT Health' 2Health News:IMPACT initiative looks to improve patient participation in clinical trials 2Health News:Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judge's Pen as Vendors Vie for Approval 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: